产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS11889 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-TERT |
克隆性 | |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetic peptide derived from human TERT |
技术外包服务:
★端粒酶逆转录酶抗体费用 分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
★蛋白工程:原核、哺乳动物蛋白表达系统等
★病毒包装:腺病毒、慢病毒等
★抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
实验流程:
端粒酶逆转录酶抗体费用 英文名称 Anti-TERT
中文名称 端粒酶逆转录酶抗体费用
别 名 EST2; hEST2; TCS1; Telomerase associated protein 2; Telomerase Catalytic Subunit; Telomere Reverse Transcriptase; Telomerase reverse transcriptase; TERT; TP2; TRT; TERT_HUMAN; Telomerase reverse transcriptase; HEST2; Telomerase catalytic subunit; Telomerase-associated protein 2.
产品属性:
浓 度 1mg/1ml
规 格 0.1ml/100μg 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat
产品类型 一抗
研究领域 细胞生物 免疫学 细胞凋亡 转录调节因子
蛋白分子量 predicted molecular weight: 124kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human TERT
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
端粒酶逆转录酶抗体费用 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. It elongates telomeres. It is a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Telomerase are large DNA-protein complexes with telomerase expression being the subject of recent research due to its link to cell immortalization. Recent evidence has shown that MYC upregulates the catalytic subunit of telomerase, TERT, and that Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008].
Function : Telomerase is a ribonucleoprotein enzyme essential for the replication of chromosome termini in most eukaryotes. Active in progenitor and cancer cells. Inactive, or very low activity, in normal somatic cells. Catalytic component of the teleromerase holoenzyme complex whose main activity is the elongation of telomeres by acting as a reverse transcriptase that adds simple sequence repeats to chromosome ends by copying a template sequence within the RNA component of the enzyme. Catalyzes the RNA-dependent extension of 3'-chromosomal termini with the 6-nucleotide telomeric repeat unit, 5'-TTAGGG-3'. The catalytic cycle involves primer binding, primer extension and release of product once the template boundary has been reached or nascent product translocation followed by further extension. More active on substrates containing 2 or 3 telomeric repeats. Telomerase activity is regulated by a number of factors including telomerase complex-associated proteins, chaperones and polypeptide modifiers. Modulates Wnt signaling. Plays important roles in aging and antiapoptosis.
Subunit : Homodimer; dimerization is required to produce a functional complex. Oligomer; can form oligomers in the absence of the telomerase RNA template component (TERC). Catalytic subunit of the telomerase holoenzyme complex composed minimally of TERT and TERC. The telomerase complex is composed of TERT, DKC1, WDR79/TCAB1, NOP10, NHP2, GAR1, TEP1, EST1A, POT1 and a telomerase RNA template component (TERC). The molecular chaperone HSP90/P23 complex is required for correct assembly and stabilization of the active telomerase. Interacts directly with HSP90A and PTGES3. Interacts with HSPA1A; the interaction occurs in the absence of TERC and dissociates once the complex has formed. Interacts with RAN; the interaction promotes nuclear export of TERT. Interacts with XPO1. Interacts with PTPN11; the interaction retains TERT in the nucleus. Interacts with NCL (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains); the interaction is important for nucleolar localization of TERT. Interacts with SMARCA4 (via the bromodomain); the interaction regulates Wnt-mediated signaling. Interacts with MCRS1 (isoform MCRS2); the interaction inhibits in vitro telomerase activity. Interacts with PIF1; the interaction has no effect on the elongation activity of TERT. Interacts with PML; the interaction recruits TERT to PML bodies and inhibits telomerase activity.
Subcellular Location : Nucleus, nucleolus. Nucleus, nucleoplasm. Nucleus. Chromosome, telomere. Cytoplasm. Nucleus, PML body. Note=Shuttling between nuclear and cytoplasm depends on cell cycle, phosphorylation states, transformation and DNA damage. Diffuse localization in the nucleoplasm. Enriched in nucleoli of certain cell types. Translocated to the cytoplasm via nuclear pores in a CRM1/RAN-dependent manner involving oxidative stress-mediated phosphorylation at Tyr-707. Dephosphorylation at this site by SHP2 retains TERT in the nucleus. Translocated to the nucleus by phosphorylation by AKT.
Tissue Specificity : Expressed at a high level in thymocyte subpopulations, at an intermediate level in tonsil T-lymphocytes, and at a low to undetectable level in peripheral blood T-lymphocytes.
Post-translational modifications : Ubiquitinated, leading to proteasomal degradation.
Phosphorylation at Tyr-707 under oxidative stress leads to translocation of TERT to the cytoplasm and reduces its antiapoptotic activity. Dephosphorylated by SHP2/PTPN11 leading to nuclear retention. Phosphorylation by the AKT pathway promotes nuclear location.
DISEASE : Note=Activation of telomerase has been implicated in cell immortalization and cancer cell pathogenesis.
Defects in TERT are associated with susceptibilty to aplastic anemia (AA) [MIM:609135]. AA is a rare disease in which the reduction of the circulating blood cells results from damage to the stem cell pool in bone marrow. In most patients, the stem cell lesion is caused by an autoimmune attack. T-lymphocytes, activated by an endogenous or exogenous, and most often unknown antigenic stimulus, secrete cytokines, including IFN-gamma, which would in turn be able to suppress hematopoiesis.
Note=Genetic variations in TERT are associated with coronary artery disease (CAD).
Defects in TERT are the cause of dyskeratosis congenital autosomal dominant type 2 (DKCA2) [MIM:613989]. A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.
Defects in TERT are the cause of dyskeratosis congenital autosomal recessive type 4 (DKCB4) [MIM:613989]. A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.
Defects in TERT are a cause of susceptibility to pulmonary fibrosis idiopathic (IPF) [MIM:178500]. Pulmonary fibrosis is a lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. It results in acute lung injury with subsequent scarring and endstage lung disease.
Similarity : Belongs to the reverse transcriptase family. Telomerase subfamily.
Contains 1 reverse transcriptase domain.
Database links :
UniProtKB/Swiss-Prot: O14746.1
Entrez Gene: 7078 Human
Entrez Gene: 21859 Mouse
Entrez Gene: 25358 Rat
Omim: 188826 Human
SwissProt: P35625 Human
SwissProt: P39876 Mouse
SwissProt: P48032 Rat
Unigene: 644633 Human
端粒酶逆转录酶hTERT是构成端粒酶的组分之一,是端粒酶活性的必需和限速成分,水平决定细胞端粒酶的活性。抑制hTERT可降低端粒酶的活性,从而抑制瘤细胞生长。目前对hTERT的研究已成为端粒酶研究的热点问题,已发现TERT蛋白表达在诊断中有重要意义,并制备了hTERT抗体及应用核酶技术等来抑制hTERT蛋白的表达,抑制端粒酶活性,从而的生长。
端粒反转录酶又称端粒酶催化亚单位 (hTRT;Telomerase catalytic subunit;HEST2;Telomerase-associated protein 2;TP2;Telomerase reverse transcriptase;telomerase catalytic subunit)是细胞永生化及发生过程中的端粒酶活化的主要限速步骤。hTRT基因表达可以反映端粒酶活性,与端粒酶活性具有平行关系。全、新、优、品、好四大特点:
端粒酶逆转录酶抗体费用 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。
新:产品更新速度较快,基本上每周都有新产品出现。
优:产品质量好,投诉比较少。
好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
正在热销的相关产品:
Tsg101(Tumor susceptibility gene 101 protein) Tsg101抗原Multi-class antibodies规格: 0.5mg
Anti-CTNNAL1 粘附分子相关蛋白a1抗体Multi-class antibodies规格: 0.1ml
Rhesus antibody Rh PDCD4 凋亡相关蛋白4抗体 规格 0.2ml
CSF1R Kit Human 人 CSF1R / MCSF Receptor / CD115 ELISA配对抗体 ELISA
TSARG2 英文名称: 形成相关凋亡蛋白2抗体 0.2ml
Casein 英文名称: 酪蛋白抗体 0.1ml
Anti-CTNNAL1 粘附分子相关蛋白a1抗体Multi-class antibodies规格: 0.1ml
NOS-2 peptide 合成酶-2多肽抗原Multi-class antibodies规格: 0.5mg
Anti-AQP2 水通道蛋白-2抗体Multi-class antibodies规格: 0.1ml
Rhesus antibody Rh phospho-ATG7(Ser95) 磷酸化自噬相关蛋白7抗体 规格 0.1ml
山羊抗人 IgM/HRP 0.1ml 美国Jackson公司分装
Viperin 英文名称: 病毒抑制蛋白Viperin抗体 0.2ml
Dio3 英文名称: 甲状腺素5'脱酶3抗体 0.1ml
Anti-AQP2 水通道蛋白-2抗体Multi-class antibodies规格: 0.1ml
Anti-SGK1/FITC 荧光素标记糖皮质激素调节激酶1抗体IgGMulti-class antibodies规格: 0.2ml
2,4-D/KLH(2,4-Dichlorophenoxyacetic acid) 2,4-二氯苯氧乙酸偶联血蓝蛋白Multi-class antibodies规格: 5mg
抗纳曲酮抗体IgG anti-Natrexone 0.1ml
SGTA 英文名称: 小谷酰胺三角四肽重复区蛋白α抗体 0.2ml
ERG3 英文名称: 癌基因ERG3抗体 0.1ml
Rhesus antibody Rh phospho-PAK3(Ser139) 磷酸化p21激活激酶3抗体 规格 0.1ml
2,4-D/KLH(2,4-Dichlorophenoxyacetic acid) 2,4-二氯苯氧乙酸偶联血蓝蛋白Multi-class antibodies规格: 5mg
大鼠膜相关磷脂酶A2(PLA2G2A)ELISA试剂盒 ,英文名: PLA2G2A ELISA Kit
人6酮素(6-K-PG)ELISA检测试剂盒Human6-keto-prostaglandin,6-K-PGELISAKit 96T/48T
羊环磷酸腺苷(cAMP)免疫试剂盒 Goat cyclic adenosine monophosphate,cAMP ELISA Kit
CLIAKitforPA-IgG/M/A(MouseplateletaibodiesIgG/M/A)ELISAKit小鼠抗血小板抗体IgG/M/A规格:48T/96T
水质砷元素比色法定量检测试剂盒20次
ELISAKitCIg人胞浆免疫球蛋白规格:48T/96T
大鼠肠碱性磷酸酶(ALPI)ELISA试剂盒 ,英文名: ALPI ELISA Kit
Rat compleme fragme 3A (C3a) ELISA Kit 大鼠补体片断3a(C3a)ELISA试剂盒
Ratghcagons-likepepfide1,GLP-1ELISAKit 大鼠胰素样肽1(Glp-1)ELISA试剂盒 96T/48T 进口分装
CLIAKitforcPLA2(RatCytosolicPhospholipaseA2,cPLA2)ELISAKit大鼠胞浆型磷脂酶A2规格:48T/96T
细胞样品细胞色素C氧化酶表达免疫荧光检测试剂盒10/20次
RatC-typenaiureticpeptide,CNPELISAKit大鼠C型尿肽(CNP)ELISA试剂盒规格:96T/48T
端粒酶逆转录酶抗体费用 大鼠淀粉样前体蛋白(βAPP)ELISA试剂盒 ,英文名: βAPP ELISA Kit
Porcine myelin basic protein (MBP) ELISA Kit 猪髓磷脂碱性蛋白(MBP)ELISA试剂盒
马铃薯特定基因序列(PATA)核酸检测试剂盒(PCR-荧光探针法) 48T
CLIAKitforLTA(HumanlymphotoxinAlpha,LTA)ELISAKit人淋巴毒素α规格:48T/96T
通用96孔1块
ELISAKitIrna鸡免疫核糖核酸规格:48T/96T